DCAF12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.681800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.717400E-01
Normal-vs-Stage2
7.628800E-01
Normal-vs-Stage3
3.298000E-02
Normal-vs-Stage4
7.814400E-01
Stage1-vs-Stage2
5.297200E-01
Stage1-vs-Stage3
1.406100E-02
Stage1-vs-Stage4
8.373800E-01
Stage2-vs-Stage3
5.731700E-02
Stage2-vs-Stage4
4.608400E-01
Stage3-vs-Stage4
4.397900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.576200E-01
Normal-vs-AfricanAmerican
8.852800E-01
Normal-vs-Asian
7.302800E-01
Caucasian-vs-AfricanAmerican
8.490600E-01
Caucasian-vs-Asian
9.851600E-01
AfricanAmerican-vs-Asian
8.549400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.070200E-01
Normal-vs-Female
7.174800E-01
Male-vs-Female
8.125000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.417000E-01
Normal-vs-Age(41-60Yrs)
8.651200E-01
Normal-vs-Age(61-80Yrs)
5.896800E-01
Normal-vs-Age(81-100Yrs)
3.258400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.225800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.809800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.654800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.902500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.257600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.342200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.671800E-01
Normal-vs-Daily Drinker
8.530600E-01
Normal-vs-Weekly Drinker
4.224000E-01
Normal-vs-Occasional Drinker
9.961200E-01
Normal-vs-Social Drinker
7.335400E-01
Non Drinker-vs-Daily Drinker
3.951800E-01
Non Drinker-vs-Weekly Drinker
5.127600E-01
Non Drinker-vs-Occasional Drinker
3.959700E-02
Non Drinker-vs-Social Drinker
1.006170E-02
Daily Drinker-vs-Weekly Drinker
6.680400E-01
Daily Drinker-vs-Occasional Drinker
6.532000E-01
Daily Drinker-vs-Social Drinker
4.117800E-01
Weekly Drinker-vs-Occasional Drinker
2.234200E-01
Weekly Drinker-vs-Social Drinker
8.833800E-02
Occasional Drinker-vs-Social Drinker
5.285200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.147600E-01
Normal-vs-Grade 2
8.934300E-02
Normal-vs-Grade 3
2.156000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.798600E-01
Grade 1-vs-Grade 3
7.499400E-01
Grade 1-vs-Grade 4
2.147600E-01
Grade 2-vs-Grade 3
6.398200E-01
Grade 2-vs-Grade 4
8.934300E-02
Grade 3-vs-Grade 4
2.156000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.645000E-01
Normal-vs-NonDiabetic
7.801000E-01
Diabetic-vs-NonDiabetic
1.360780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.626400E-01
Normal-vs-NoPancreatitis
7.426600E-01
Pancreatitis-vs-NoPancreatitis
4.509600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.426000E-01
Normal-vs-N1
8.109600E-01
N0-vs-N1
7.997200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.088000E-01
Normal-vs-TP53-NonMutant
9.204600E-01
TP53-Mutant-vs-TP53-NonMutant
4.733400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
